M. Kraml
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Biochemistry top 10%
Papers in
-
- Steroid Chemistry and Biochemistry 6
- Metabolomics and Mass Spectrometry Studies 5
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 10
- Inflammatory mediators and NSAID effects 9
- Drug-Induced Hepatotoxicity and Protection 6
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- D. Dvornik (27 shared papers)J.-E. Dubuc (18 shared papers)David Hicks (15 shared papers)Jehan F. Bagli (4 shared papers)Roger Gaudry (6 shared papers)Morris L. Givner (4 shared papers)Mitchell N. Cayen (9 shared papers)Leslie G. Humber (6 shared papers)
- Journals
- Clinical Biochemistry (7 papers)Clinical Pharmacology & Therapeutics (7 papers)Journal of Medicinal Chemistry (5 papers)Biochemical Pharmacology (3 papers)Xenobiotica (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
M. Kraml
65 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 116
- Pharmacology 172
- Pharmacology 200
- Biochemistry 74
- Analytical Chemistry 99
- Pharmaceutical Science 55
Countries citing papers authored by M. Kraml
This map shows the geographic impact of M. Kraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kraml more than expected).
Fields of papers citing papers by M. Kraml
This network shows the impact of papers produced by M. Kraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kraml. The network helps show where M. Kraml may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Kraml, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1966 | 216 | |
| 2 | 1963 | 124 | |
| 3 | 1994 | 72 | |
| 4 | 1981 | 51 | |
| 5 | 1964 | 48 | |
| 6 | 1966 | 46 | |
| 7 | 1968 | 34 | |
| 8 | 2017 | 33 | |
| 9 | 1964 | 33 | |
| 10 | 1964 | 28 | |
| 11 | 1967 | 27 | |
| 12 | 1988 | 25 | |
| 13 | 1984 | 24 | |
| 14 | 1966 | 24 | |
| 15 | 1962 | 22 | |
| 16 | 2016 | 20 | |
| 17 | 1955 | 19 | |
| 18 | 1983 | 19 | |
| 19 | Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man. | 1962 | 19 |
| 20 | 1963 | 18 |
About M. Kraml
M. Kraml is a scholar working on Molecular Biology, Pharmacology, Surgery, Pharmacology and Analytical Chemistry, having authored 66 papers that have together received 1.2k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (11 papers), Cholesterol and Lipid Metabolism (10 papers), Pharmacogenetics and Drug Metabolism (10 papers), Inflammatory mediators and NSAID effects (9 papers), Steroid Chemistry and Biochemistry (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Pharmacology (172 citations), Pharmacology (200 citations), Biochemistry (74 citations), Analytical Chemistry (99 citations) and Pharmaceutical Science (55 citations). M. Kraml has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include D. Dvornik, J.-E. Dubuc, David Hicks, Jehan F. Bagli, Roger Gaudry, Morris L. Givner, Mitchell N. Cayen, Leslie G. Humber, E. Greselin and Eckhardt S. Ferdinandi. Their work appears in journals such as Clinical Biochemistry, Clinical Pharmacology & Therapeutics, Journal of Medicinal Chemistry, Biochemical Pharmacology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.